M&A Deal Summary |
|
---|---|
Date | 2020-07-16 |
Target | Elanco Animal Health - StandGuard |
Sector | Consumer Products |
Buyer(s) | Neogen |
Sellers(s) | Elanco |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1981 |
Sector | Test/Measurement Equipment |
Employees | 2,640 |
Revenue | 822M USD (2023) |
Neogen develops and markets products dedicated to food and animal safety. The Company's food safety division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen was founded in 1981 and is based in Lansing, Michigan.
DEAL STATS | # |
---|---|
Overall | 26 of 30 |
Sector (Consumer Products) | 2 of 3 |
Type (Divestiture) | 5 of 5 |
State (Indiana) | 1 of 1 |
Country (United States) | 13 of 15 |
Year (2020) | 5 of 5 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-03-31 |
Magiar Chilena SA
Penalolen, Chile Magiar Chilena SA is a distributor of food, animal, and plant diagnostics, including NEOGEN products. Magiar Chilena is based in Penalolen, Chile. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-01-04 |
Megazyme
Wicklow, Ireland Megazyme Ltd. is a provider of analytical solutions used by quality control laboratories in the global food and beverage industries. Megazyme develops and refining analytical methods used to measure the carbohydrates and enzymes in grain and cereal products that affect quality. Megazyme was founded in 1988 and is based in Wicklow, Ireland. |
Buy | - |
Category | Company |
---|---|
Founded | 1954 |
Sector | Life Science |
Employees | 9,300 |
Revenue | 4.4B USD (2023) |
Elanco develops and markets products and services to improve animal health and protein production in more than 75 countries. Elanco employs more than 3,000 people worldwide, with offices in more than 40 countries. Elanco was incorporated in 1954 and is based in Greenfield, Indiana.
DEAL STATS | # |
---|---|
Overall | 2 of 3 |
Sector (Consumer Products) | 1 of 1 |
Type (Divestiture) | 2 of 3 |
State (Indiana) | 2 of 3 |
Country (United States) | 2 of 3 |
Year (2020) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-01-13 |
Elanco Animal Health - Capstar
Greenfield, Indiana, United States Elanco Animal Health, Inc. - Capstar is an oral over-the-counter (“OTC”) flea treatment product in the United States. The Capstar portfolio is comprised of seven SKUs, including three private-label SKUs that are sold under the Capaction® brand. Capstar® is an oral tablet for the treatment of flea infestations on dogs, puppies, cats, and kittens and is currently the best-selling oral OTC flea treatment product in the United States. |
Sell | $95M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-06-16 |
Kindred Biosciences
Burlingame, California, United States Kindred Biosciences is a biopharmaceutical company developing biologics focused to develop therapeutics based on these validated targets for dogs and cats. Kindred Biosciences was founded in 2012 and is based in Burlingame, California. |
Buy | $440M |